Arsenic alters cytosine methylation patterns of the promoter of the tumor suppressor gene p53 in human lung cells: a model for a mechanism of carcinogenesis
- PMID: 9219564
- DOI: 10.1016/s1383-5742(97)00008-2
Arsenic alters cytosine methylation patterns of the promoter of the tumor suppressor gene p53 in human lung cells: a model for a mechanism of carcinogenesis
Abstract
Arsenic is a potent human carcinogen to which there is significant worldwide exposure through natural contamination of food and drinking water sources. Because arsenic is detoxified via methylation using a methyltransferase (MTase) and S-adenosylmethionine (SAM) as the methyl donor, we hypothesized that a mechanism of carcinogenesis of arsenic could involve alterations of MTase/SAM-dependent DNA methylation of a tumor suppressor gene. We found that exposure of human lung adenocarcinoma A549 cells to sodium arsenite (0.08-2 microM) or sodium arsenate (30-300 microM), but not dimethylarsenic acid (2-2000 microM), produced significant dose-responsive hypermethylation within a 341-base pair fragment of the promoter of p53. This was determined by quantitative PCR/HpaII restriction site analysis to analyze methylation status of two CCGG sites. In experiments with arsenite, DNA sequencing using bisulfite to visualize 5-methylcytosine (5-MeC) over the entire promoter region confirmed data obtained by restriction analysis. Limited data using SssI methylase also suggested that over-methylation of CpG sequences may exist over the entire genome in response to arsenite exposure. We propose that alteration of DNA methylation by arsenic offers a plausible, unified hypothesis for the carcinogenic mechanism of action of arsenic, and we present a model for arsenic carcinogenesis that utilizes perturbations of DNA methylation as the basis for the carcinogenic effects of arsenic.
Similar articles
-
Epigenetic mechanisms underlying arsenic-associated lung carcinogenesis.Arch Toxicol. 2015 Nov;89(11):1959-69. doi: 10.1007/s00204-014-1351-2. Epub 2014 Sep 9. Arch Toxicol. 2015. PMID: 25199682
-
Effects of arsenic exposure on DNA methylation in cord blood samples from newborn babies and in a human lymphoblast cell line.Environ Health. 2012 May 2;11:31. doi: 10.1186/1476-069X-11-31. Environ Health. 2012. PMID: 22551203 Free PMC article.
-
DNA hypermethylation of promoter of gene p53 and p16 in arsenic-exposed people with and without malignancy.Toxicol Sci. 2006 Feb;89(2):431-7. doi: 10.1093/toxsci/kfj030. Epub 2005 Oct 26. Toxicol Sci. 2006. PMID: 16251483
-
Gene methylation in gastric cancer.Clin Chim Acta. 2013 Sep 23;424:53-65. doi: 10.1016/j.cca.2013.05.002. Epub 2013 May 10. Clin Chim Acta. 2013. PMID: 23669186 Review.
-
Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites.Toxicol Appl Pharmacol. 2001 May 1;172(3):249-61. doi: 10.1006/taap.2001.9157. Toxicol Appl Pharmacol. 2001. PMID: 11312654 Review.
Cited by
-
Arsenic causing gallbladder cancer disease in Bihar.Sci Rep. 2023 Mar 14;13(1):4259. doi: 10.1038/s41598-023-30898-0. Sci Rep. 2023. PMID: 36918592 Free PMC article.
-
Epigenomic reprogramming in iAs-mediated carcinogenesis.Adv Pharmacol. 2023;96:319-365. doi: 10.1016/bs.apha.2022.08.004. Epub 2022 Oct 26. Adv Pharmacol. 2023. PMID: 36858778 Free PMC article.
-
Biotechnology Advances in Bioremediation of Arsenic: A Review.Molecules. 2023 Feb 3;28(3):1474. doi: 10.3390/molecules28031474. Molecules. 2023. PMID: 36771138 Free PMC article. Review.
-
Missing Causality and Heritability of Autoimmune Hepatitis.Dig Dis Sci. 2023 Apr;68(4):1585-1604. doi: 10.1007/s10620-022-07728-w. Epub 2022 Oct 19. Dig Dis Sci. 2023. PMID: 36261672
-
A Comprehensive Transcriptomic Analysis of Arsenic-Induced Bladder Carcinogenesis.Cells. 2022 Aug 5;11(15):2435. doi: 10.3390/cells11152435. Cells. 2022. PMID: 35954277 Free PMC article.
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous